Development and validation of the TGx-HDACi transcriptomic biomarker to detect histone deacetylase inhibitors in human TK6 cells.

MLA

Cho, Eunnara, et al. “Development and Validation of the TGx-HDACi Transcriptomic Biomarker to Detect Histone Deacetylase Inhibitors in Human TK6 Cells.” Archives of Toxicology, vol. 95, no. 5, May 2021, pp. 1631–45. EBSCOhost, https://doi.org/10.1007/s00204-021-03014-2.

APA

Cho, E., Rowan-Carroll, A., Williams, A., Corton, J. C., Li, H.-H., Fornace, A. J., Jr, Hobbs, C. A., & Yauk, C. L. (2021). Development and validation of the TGx-HDACi transcriptomic biomarker to detect histone deacetylase inhibitors in human TK6 cells. Archives of Toxicology, 95(5), 1631–1645. https://doi.org/10.1007/s00204-021-03014-2

Chicago

Cho, Eunnara, Andrea Rowan-Carroll, Andrew Williams, J Christopher Corton, Heng-Hong Li, Albert J Fornace Jr, Cheryl A Hobbs, and Carole L Yauk. 2021. “Development and Validation of the TGx-HDACi Transcriptomic Biomarker to Detect Histone Deacetylase Inhibitors in Human TK6 Cells.” Archives of Toxicology 95 (5): 1631–45. doi:10.1007/s00204-021-03014-2.